NanoVibronix ( (NAOV) ) has provided an update.
NanoVibronix, a company involved in the medical device sector, held its Annual Meeting where stockholders approved all proposals, including the election of directors and the ratification of an independent auditor, for the fiscal year 2024. Additionally, the approval of a long-term incentive plan and executive compensation were sanctioned, reinforcing the company’s governance structure and strategic plans.
More about NanoVibronix
YTD Price Performance: -49.22%
Average Trading Volume: 395,091
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.19M
See more insights into NAOV stock on TipRanks’ Stock Analysis page.